<DOC>
	<DOCNO>NCT00567749</DOCNO>
	<brief_summary>This study establish clinical sensitivity Chembio Diagnostics Systems , Inc. Clearview COMPLETE HIV 1/2 Assay Clearview HIV 1/2 Stat-Pak Assay ( Clearview HIV test ) pediatric subject 12 17 year age . A minimum ten ( 10 ) know HIV-positive participant test .</brief_summary>
	<brief_title>Clinical Sensitivity Clearview Rapid Tests 12-17 y/o Pediatric Population</brief_title>
	<detailed_description>In order achieve primary objective , clinical trial conduct establish confirm sensitivity Clearview HIV 1/2 test describe pediatric population . Only HIV-1 include study . The Clearview HIV test use safe effective screen method aid diagnosis infection HIV 1/2 pediatric population age 12 17 year . The secondary objective study include demonstrate : - The Clearview HIV test detect HIV-1 antibody variety sample matrix : capillary ( fingertip ) whole blood , venous whole blood , plasma serum .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<criteria>Must least 12 year age old 17 year age . Must willing sign ( give ) copy write Information Assent Form . Must parent guardian present sign receive copy Informed Consent Form . Must able provide one two fingerstick blood sample . Must able provide three tube blood venipuncture arm hand . Have life threaten illness ( exception HIV AIDS ) . Have suppress immune system ( i.e . transplant patient , individual diagnose nonHIV immunosuppressive illness , etc . ) , determine interview study participant parent/legal guardian . Have participate participate clinical trial HIV vaccine ( determine interview study participant parent/legal guardian ) . Have previously participate clinical trial ( duplicate enrollment ) . Are currently HAART , except agree casebycase basis .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>HIV-1 Infections</keyword>
</DOC>